TRANSCENDPRP Trademark

Trademark Overview

On Wednesday, November 23, 2022, a trademark application was filed for TRANSCENDPRP with the United States Patent and Trademark Office. The USPTO has given the TRANSCENDPRP trademark a serial number of 97690410. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, September 12, 2024. This trademark is owned by Transcend Biologics, LLC. The TRANSCENDPRP trademark is filed in the Medical Instrument Products category with the following description:

Blood component separation apparatus for medical purposes
transcendprp

General Information

Serial Number97690410
Word MarkTRANSCENDPRP
Filing DateWednesday, November 23, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

Description of MarkThe mark consists of the words "transcendPRP" next to a stylized DNA strand.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBlood component separation apparatus for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 16, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranscend Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056
Party NameTranscend Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056

Trademark Events

Event DateEvent Description
Saturday, November 26, 2022NEW APPLICATION ENTERED
Friday, December 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 17, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 5, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 12, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, December 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU EXTENSION 1 FILED
Thursday, September 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

transcendprp medical purposes apparatus separation component blood